A non-invasive, at-home electrical stimulation device significantly reduced post-traumatic stress disorder symptoms, acute anxiety, and insomnia in a recent clinical trial published in Nature Mental Health. The trial evaluated 383 patients who used the low-current device to target the vestibular system in the inner ear.
Clinical Trial Results for Vestibular Stimulation
The clinical study tested the Modius Spero device on 383 participants ranging in age from 22 to 74 years old. Patients administered the electrical stimulation behind the ear for 30 minutes daily before bedtime. According to the published findings in Nature Mental Health, participants using the active device experienced a reduction in symptom severity that was twice the improvement recorded by patients in the control group who received sham treatments.
Researchers observed that the intervention not only alleviated PTSD symptoms but also helped stabilize psychological well-being and improved overall quality of life for the participants. The approach offers a non-surgical alternative for managing chronic psychiatric conditions from home.
How the Modius Spero Treatment Works
The therapy relies on transcutaneous electrical vestibular nerve stimulation delivered via a specialized headset worn behind the ear.
Treatments lasting 30 minutes daily can be completed independently before sleep, bypassing the need for complex clinical interventions or invasive procedures.
Implications for Chronic Psychiatric Care
The findings point toward a shift in how chronic psychiatric symptoms like severe anxiety and insomnia can be managed outside of clinical settings. Non-invasive neurostimulation provides an option that patients can integrate into their nightly routines.
The trial's scale—involving 383 individuals across a broad age range—offers strong data supporting the safety and efficacy of vestibular nerve stimulation for psychiatric symptoms.
Related reading